611 related articles for article (PubMed ID: 19356530)
1. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
Kwon DH; Halley CM; Carrigan TP; Zysek V; Popovic ZB; Setser R; Schoenhagen P; Starling RC; Flamm SD; Desai MY
JACC Cardiovasc Imaging; 2009 Jan; 2(1):34-44. PubMed ID: 19356530
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance.
Kwon DH; Halley CM; Popovic ZB; Carrigan TP; Zysek V; Setser R; Schoenhagen P; Flamm SD; Starling RC; Desai MY
Eur J Heart Fail; 2009 Oct; 11(10):937-44. PubMed ID: 19789396
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for diastolic function assessment in era of delayed enhancement cardiac magnetic resonance imaging?: a multimodality imaging study in patients with advanced ischemic cardiomyopathy.
Cavalcante JL; Marwick TH; Hachamovitch R; Popovic ZB; Aldweib N; Starling RC; Desai MY; Flamm SD; Kwon DH
Am Heart J; 2014 Aug; 168(2):220-8.e1. PubMed ID: 25066562
[TBL] [Abstract][Full Text] [Related]
4. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
5. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
[TBL] [Abstract][Full Text] [Related]
7. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
[TBL] [Abstract][Full Text] [Related]
8. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty.
Miszalski-Jamka T; Klimeczek P; Tomala M; Krupiński M; Zawadowski G; Noelting J; Lada M; Sip K; Banyś R; Mazur W; Kereiakes DJ; Zmudka K; Pasowicz M
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1237-46. PubMed ID: 21163452
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of cardiac tissue structure and function for improved identification of reversible myocardial dysfunction.
Hoffmann R; Stempel K; Kühl H; Balzer J; Krämer N; Krombach G; Kelm M; Becker M
Coron Artery Dis; 2009 Jan; 20(1):21-6. PubMed ID: 19008764
[TBL] [Abstract][Full Text] [Related]
10. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
[TBL] [Abstract][Full Text] [Related]
11. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
[TBL] [Abstract][Full Text] [Related]
12. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
[TBL] [Abstract][Full Text] [Related]
13. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
[TBL] [Abstract][Full Text] [Related]
14. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
McLellan AJ; McKenzie SC; Taylor AJ
Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
[TBL] [Abstract][Full Text] [Related]
16. Infarct characterization and quantification by delayed enhancement cardiac magnetic resonance imaging is a powerful independent and incremental predictor of mortality in patients with advanced ischemic cardiomyopathy.
Kwon DH; Asamoto L; Popovic ZB; Kusunose K; Robinson M; Desai M; Marwick TH; Flamm SD
Circ Cardiovasc Imaging; 2014 Sep; 7(5):796-804. PubMed ID: 25085923
[TBL] [Abstract][Full Text] [Related]
17. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.
Vincenti G; Masci PG; Monney P; Rutz T; Hugelshofer S; Gaxherri M; Muller O; Iglesias JF; Eeckhout E; Lorenzoni V; Pellaton C; Sierro C; Schwitter J
JACC Cardiovasc Imaging; 2017 May; 10(5):526-537. PubMed ID: 28412420
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study.
Scott PA; Rosengarten JA; Murday DC; Peebles CR; Harden SP; Curzen NP; Morgan JM
J Cardiovasc Electrophysiol; 2013 Apr; 24(4):430-6. PubMed ID: 23210601
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.
Kim J; Kochav JD; Gurevich S; Afroz A; Petashnick M; Volo S; Diaz B; Okin PM; Horn E; Devereux RB; Weinsaft JW
Int J Cardiovasc Imaging; 2014 Dec; 30(8):1559-67. PubMed ID: 25008088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]